Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
Elisabetta Vergani(Fondazione IRCCS Istituto Nazionale dei Tumori), Laura Gatti(Fondazione IRCCS Istituto Neurologico Carlo Besta)
Cited by 35
Related Papers
Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
|International Journal of Molecular Sciences|2020|86
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
|Cell Communication and Signaling|2020|34